Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has received a US$ 6.6 m grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis (“TB”). The grant is the second award from the foundation to Evotec supporting TB drug ...
Gabriele Hansen Werner Lanthaler Robert Koch Hinnerk Rohwedder Volker Braun Melinda Gates Foundation
Source: pharmiweb.com